Watch: Trump signs executive order easing U.S. restrictions on psychedelic research
President Trump signed an executive order Saturday that eases restrictions on the research of the psychedelics including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder.
Read MoreTrump announces reforms to accelerate access to psychedelic drug treatments
President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaineDonald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs.The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a…
Read MoreTrump signs order to speed review of psychedelics, including the controversial drug ibogaine
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine
Read MoreTrump signs order to research psychedelic used abroad to treat PTSD
The executive order will open the door for more research into the psychedelic drug ibogaine, sources told CBS News earlier this week.
Read MoreTrump to sign executive order on psychedelic drug used abroad to treat PTSD
Ibogaine is used in Mexico and the Caribbean to treat depression, anxiety, addiction and brain trauma.
Read More